BAYER AG |
Market Closed -
Other stock markets
|
After market 02:47:19 pm | |||
| 26.97 EUR | -1.37% |
|
27.02 | +0.20% |
| 03:36pm | German cabinet approves restricted use of herbicide glyphosate | RE |
| 05:52am | Dehoga: Challenging situation for company canteens | DP |
| Sales 2024 * | 47.23B 50.51B | Sales 2025 * | 48.15B 51.5B | Capitalization | 26.86B 28.73B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.08B 2.23B | Net income 2025 * | 3.17B 3.39B | EV / Sales 2024 * | 1.26 x |
| Net Debt 2024 * | 32.69B 34.97B | Net Debt 2025 * | 29.48B 31.53B | EV / Sales 2025 * | 1.17 x |
| P/E ratio 2024 * |
12.5
x | P/E ratio 2025 * |
8.41
x | Employees | 96,931 |
| Yield 2024 * |
0.4% | Yield 2025 * |
0.88% | Free-Float | 99.97% |
More Fundamentals
* Assessed data
More news
Latest transcript on Bayer AG
More press releases
More news
| 1 day | -1.23% | ||
| 1 week | +2.74% | ||
| Current month | -5.14% | ||
| 1 month | +0.48% | ||
| 3 months | -17.33% | ||
| 6 months | -34.67% | ||
| Current year | -19.80% |
1 week
25.61
27.70
1 month
25.6128.94
Current year
24.9636.09
1 year
24.9660.81
3 years
24.9667.99
5 years
24.9678.34
10 years
24.96146.45
| Managers | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 23-03-31 |
| Director of Finance/CFO | 54 | 18-04-25 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 17-03-31 |
| Director/Board Member | 68 | 17-03-31 | |
Alberto Weisser
BRD | Director/Board Member | 67 | 21-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 9.77% | 70 M€ | -.--% | - | |
| 5.71% | 2 M€ | +13.56% | - | |
| 4.28% | 962 M€ | -.--% | - | |
| 4.10% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 26.97 | -1.37% | 2 710 724 |
| 24-04-23 | 27.34 | +0.11% | 3,055,329 |
| 24-04-22 | 27.32 | +3.76% | 4,999,901 |
| 24-04-19 | 26.32 | +0.32% | 4,224,860 |
| 24-04-18 | 26.24 | -0.04% | 2,759,804 |
Delayed Quote Xetra, April 24, 2024 at 11:35 am EDT
More quotes
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
2024-04-26
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
27.34
EUR
Average target price
37.05
EUR
Spread / Average Target
+35.48%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -19.80% | 28.74B | |
| +26.07% | 672B | |
| +25.87% | 570B | |
| -5.24% | 360B | |
| +16.65% | 321B | |
| +8.54% | 300B | |
| +7.09% | 217B | |
| -9.12% | 204B | |
| +5.01% | 199B | |
| -8.68% | 149B |
- Stock Market
- Equities
- BAYN Stock
